An investigation on behalf of investors in GSK plc (NYSE:GSK) shares over potential wrongdoing at GSK plc (NYSE: GSK was announced.

San Diego, CA -- (SBWire) -- 10/21/2022 --An investigation was announced on behalf of investors in NYSE: GSK shares over potential breaches of fiduciary duties by certain officers and directors at GSK plc.

Investors who purchased shares of GSK plc (NYSE: GSK) and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain GSK directors breached their fiduciary duties and caused damage to the company and its shareholders.

United Kingdom based GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally.

On August 9, 2022, Vir Biotechnology, Inc. provided a corporate update and reported its second quarter 2022 financial results. Among other things, Vir Biotechnology, Inc., also stated that "Due to the evolving COVID-19 landscape and based on discussions with the US Food and Drug Administration (FDA), the Company and GSK do not plan to file a Biologics License Application for sotrovimab at this time and do not intend to pursue the US-based Phase 3 COMET-STAR prophylaxis trial. Discussions with the FDA remain ongoing regarding the appropriate path forward for sotrovimab in the US."

Those who purchased shares of GSK plc (NYSE: GSK) have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Christopher Clausen
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

About The Shareholders Foundation
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigation, and/or settlements are not filed/reached and/or related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.